The U.S. Senate Committee on Finance has extended its probe of pharmaceutical industry educational grants by sending a letter of inquiry to the Accreditation Council for CME. The December 19 letter, available at, explains that the committee is continuing to review marketing practices that influence physicians' prescribing patterns. As we've reported in previous issues, the committee's inquiry began in June 2005. Concerned that grants may sometimes be used for influence ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock the Senate Spotlights CME, you'll also gain access to exclusive premium content.

Already registered? here.